DOTmed polled service companies about how to ensure that DXA units operative efficiently.
Men need to be aware of potentially disabling condition.
Use of ultrasound works better than blind biopsy, research indicates.
Communications campaign provides targeted outreach to most affected populations.
$2 billion funding will support immunization and public information campaigns.
Grant funding will go to improve patient-centered medical homes.
Plans for insurance reform have public and private options competing. Read DOTmed's exclusive coverage of a report that will influence policy-makers as they move forward.
Bills would provide for prostate cancer imaging and ovarian biomarker research.
Building resilient structures and training health workers are recommended actions.
Technology developed by New York's Wadsworth Center and Washington University.
Bracco Diagnostics can recover costs of corrective advertising for claims regarding competing contrast mediums. DOTmed summarizes the decision.
Read a DOTmed exclusive update including expert insight on security concerns and best practices.
Law requires registration, will limit new facilities, limit referrals.
Department says hospital staff over-exposed patient in CT.
Stent is hoped to eventually be a new standard for care of coronary artery disease.
Program offers Certificate of Distinction for exceptional efforts to foster better outcomes for heart failure patients.
Report describes how IT is being used throughout the U.S.
DOTmed speaks to compliance expert on the new concerns.
Remote care system now has alerts for atrial fibrillation, new Spanish language option.
Brief discusses eligibility, funding and other options.
Legislation would coordinate research, streamline approval process on treatments.
Office will distribute the $137 billion in Recovery Act Funds.
The site, www.healthreform.gov, offers information on health care forums, new HHS report on community health care discussions.
Top 100 free-standing imaging center CEOs to meet in North San Diego, CA, March 22-24 2009. Panel topics to include imaging industry financial and political issues. Read DOTmed's exclusive preview.
Plan would allow for an additional 100 nurses to be trained per year in city with nursing shortage.
President Obama also has a new directive to "restore scientific integrity" to government decision-making.
Cardiovascular and metabolic disease develops from circadian misalignment, study suggests.
Get it at a glance: the health care expenditures and financing in the President's proposed budget.
Court order declares Arkansas hospital system's economic credentialing to be contrary to public policy.
A DOTmed exclusive roundup of medico-legal news.
A DOTmed exclusive look at a fascinating intersection of two important disciplines.
Other health insurers should reject database, AMA president urges.
Report stresses concern over disparity, suggests more education.
Biomarker use will be for prostate cancer test development.
Organization expresses concern over higher health risk, lower prevention rates.
Advocacy group approves of legislation to research effectiveness of health care treatments.
Connectivity means time saved for hospitals through automatic data transfer.
Industry insiders testify as to effect of bidding on small businesses.
Study will begin on laws for simulation enhancement, public health, veterans' medical care. Read a DOTmed exclusive legislative roundup.
Questions on new issues of privacy laws examined in report.
Don't "wait and see," expert recommends, think about compliance now. Read this DOTmed exclusive report that puts the law in clear focus. (Audio conference Feb. 19.)
Early major step in President's health care agenda completed.
DOTmed Certified user's lifelong hobbies pay off in a long career, solid business.
Stem cell device part of University of Naples therapy trials.
PCR platform system passes initial phase of alpha testing program.
Agency says these are next steps before restarting Competitive Bidding Program for DMEPOS.
In addition to current line, company will also market EnCor globally. SenoRx develops, manufactures and sells minimally invasive medical devices for the diagnosis and treatment of breast cancer.
Study indicates "epidemic," agency says.
New article says treatment works better tailored to age, injury and symptoms.
Report features preparedness accomplishments and challenges for the future.